Proliferation, carcinogen risk assessment

Altmann GG, Lala PK. 1991. Control of 1,2-dimethylhydrazine-induccd crypt hyperplasia by natural-killer cells and its relevance to carcinogenics. In Chemically induced cell proliferation Implications for risk assessment. New York, NY Wiley-Liss, Inc. 417-428. 

Kluwe, W.M. (1994). The relevance of hepatic peroxisome proliferation in rats to assessment of human carcinogenic risk for pharmaceuticals. Regul. Toxicol. Pharmacol. 20, 170-186. 

J. McCann and B. N. Ames, The Salmonella/micvosomt mutagenicity test Predictive value for animal carcinogenicity, in Origins of Human Cancer (H. H. Hiatt, J. D. Watson, and J. A. Winsten, eds.), Book C, Human Risk Assessment, Cold Spring Harbor Conferences on Cell Proliferation, Vol. 4, pp. 1513-1520, Cold Spring Harbor Laboratory (1977). 

Meeker JD, Calafat AM, Hauser R (2007) Di(2-ethyUiexyl) phthalate metabolites may alter thyroid hormone levels in men. Environ Health Perspect 115(7) 1029-1034 Melnick RL (2001) Is peroxisome proliferation an obligatory precursor step in the carcinogenicity of di(2-ethylhexyl)phthalate (DEHP) Environ Health Perspect 109(5) 437-442 Montuori P, Jover E, Morgantini M et al (2008) Assessing human exposure to phthalic acid and phthalate esters from mineral water stored in polyethylene terephthalate and glass bottles. Food Addit Contam Part A Chem Anal Control Expo Risk Assess 25(4) 511-518... 

---